US EditionFirst Topaz tricuspid valve implanted in European pivotal study
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First Topaz tricuspid valve implanted in European pivotal study
TRiCares SAS has announced the first implantation of its Topaz transfemoral tricuspid heart valve replacement system in a pivotal study in Europe. The TRICURE European pivotal study is taking place at sites in Germany, Belgium, France and Switzerland, with additional countries expected to follow. The study will assess the safety and efficacy of Topaz in patients with significant tricuspid regurgitation (TR) who are not candidates for open heart …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
